What is SalivIQ Diagnostics?
SalivIQ Diagnostics is a pioneering biotechnology firm dedicated to the development of innovative saliva-based diagnostic solutions. The company's core mission revolves around the early detection and continuous monitoring of various diseases. By harnessing advanced non-invasive testing technologies and conducting in-depth biomarker research, SalivIQ Diagnostics aims to deliver accessible, efficient, and patient-centric diagnostic tools. These solutions are designed to empower healthcare providers, enhance clinical decision-making processes, and propel the advancement of precision medicine applications.
How much funding has SalivIQ Diagnostics raised?
SalivIQ Diagnostics has raised a total of $1.2M across 1 funding round:
Private Equity
$1.2M
Private Equity (2026): $1.2M, investors not publicly disclosed
What's next for SalivIQ Diagnostics?
The substantial enterprise-level funding and recent strategic investment signal a pivotal growth phase for SalivIQ Diagnostics. This capital infusion is expected to accelerate product development, expand research initiatives, and bolster market penetration for its saliva-based diagnostic technologies. The company is strategically positioned to capitalize on the growing demand for non-invasive and accessible healthcare solutions, potentially leading to broader adoption in clinical settings and further innovation in disease detection and management.
See full SalivIQ Diagnostics company page
